Biopharmaceuticals are preparations synthesized from living organisms, especially a human or animal protein, such as a hormone or antitoxin that is used as a diagnostic, preventive, or therapeutic agent. If the preparation is the original drug, it can be patented. Most of us have seen TV adverts for patented new wonder drugs such as Humira, […]
As the new legislative session begins, Congress should demand increased transparency, require flow-through of manufacturer rebates to lower consumer prices, prohibit clawbacks, and consider giving federal agencies expanded oversight responsibilities to monitor PBMs’ practices. This op-ed explains why.
Today, the American Consumer Institute Center for Citizen Research (ACI) announced the release of its latest ConsumerGram, highlighting the promise of new gene replacement therapies and urging health care stakeholders to develop innovative ways of financing these important treatments. The report, authored by Dr. Joseph Fuhr, Liam Sigaud and Steve Pociask, describes the economic benefits […]
In January 2019, Lancet released a study attempting to define a stingy but adequate human diet and a political pathway to reining in global agricultural and food processing industries. Lancet acknowledged that its medical and political science agenda allowed it to rely on medical experts for some subject matter but forced it to concede judgements […]
The Governor of Washington State has declared a state of emergency resulting from an outbreak of 35 cases of measles. “Thirty of the cases involved people who have not had a measles immunization.” Most cases are children. Already two children left Washington State taking measles with them to Hawaii where they were quarantined. When parents […]
The global wearable medical devices market is expected to grow at a compound rate of 18.0% during the period 2015 to 2023, increasing from $2.7 billion in 2014 to $10 billion by the end of 2033. While we do not want to spend more, many of the new wearable devices will deliver better care and […]
Health care costs are consuming 18% of GDP and growing at a pace faster than the overall economy. If that continues, health costs could crowd out other high priority programs in education, defense, research, and public safety. Each of us has a stake in assuring that health care funds are spent where they do the […]
A massive, yet often unnoticed, business practice contributing to exorbitant drug prices in the U.S. may slowly be moving toward reform, according to a recent announcement by the largest practitioner. To read this op-ed, please visit Real Clear Health.
The harmful and anti-competitive business practices that PBMs thrive on are made possible by the industry’s secrecy and lack of transparency. Plan sponsors and beneficiaries should be given more information about how their insurance plans are managed and what rates are negotiated. Pharmacies should be allowed, and even encouraged, to point customers to lower-cost alternatives […]
The news coverage about pre-existing conditions leave out a lot. Popular media outlets focus on government operated public plans such as the Affordable Care Act (ACA) health insurance exchange options, or Medicare, or Medicaid. Often neglected are the employer-provided health benefit plans and short-term health insurance plans. Many health care benefit plans are available for […]